Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: RR5U4UFJ8L

Pharmacology

Action Mechanism of Action Reference
INHIBITOR CD70 antigen inhibitor PubMed Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Myelodysplastic Syndromes 1 D009190 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1864871-20-4
ChEMBL CHEMBL4297891
FDA SRS RR5U4UFJ8L
Guide to Pharmacology 9778